HoldsUp

Jeffrey Bland

Jeffrey Bland is a researcher and practitioner working in the fields of functional, integrative, and personalized lifestyle medicine. His published research focuses on functional nutrition, metabolic health, and the effects of dietary supplements and polyphenols on immune function and biological markers. He also writes on the evolution of healthcare paradigms, including nutrition education in medical schools and personalized wellness interventions.

21 claims checked on air: 5 context 3 contradicted 2 overstated 3 supported 8 unverified

What they said on air - citing their own research

3 citing their own research

0:15:01needs contextlowtheir own paperA Closer Look At Immune Health & Himalayan Tartary Buckwheat

Tartary buckwheat contains over 150 different immune-active phytochemicals.

"It has over 150 different immune-active uh phytochemicals, plant-derived uh substances." (said at 0:15:01)

Comprehensive metabolomic profiling of Tartary buckwheat (Fagopyrum tataricum) has identified hundreds of secondary metabolites and phytochemicals, including numerous flavonoids, phenolic acids, anthraquinones, fagopyritols, and triterpenoids. Broad classes of these compounds exhibit anti-inflammatory, antioxidant, and immunomodulatory activities in preclinical models, and Tartary buckwheat concentrates have shown effects on immune-related gene pathways and epigenetic clocks in preliminary human trials. However, the designation of 'over 150 immune-active' compounds reflects untargeted metabolomic detection of phytochemical constituents rather than 150 individually characterized and clinically validated human immune-modulating agents.

0:31:19needs contextvery lowtheir own paperA Closer Look At Immune Health & Himalayan Tartary Buckwheat

In a 50-person clinical trial, supplementation for 90 days with Himalayan Tartary Buckwheat polyphenols reduced participants' epigenetic immune age by 47%.

"in which we found in 50 individuals that those individuals who consumed the the matrix of these polyphenols found in Himalayan Tartary Buckwheat who started off with an aged immune system and we can measure that looking at the epigenetic age using various age algorithms uh that after 90 days of supplementation lo and behold it lowered their immune age by 47%." (said at 0:31:19)

The speaker accurately describes the results of an open-label, single-arm pilot clinical trial (PMID 39628466) involving 50 participants who consumed a Himalayan Tartary Buckwheat polyphenol supplement for 90 days. In that study, epigenetic clock algorithms were used to estimate biological and immune age, reporting reductions in epigenetic immune age, particularly among participants exhibiting accelerated baseline immune aging. However, context is needed because the study lacked a placebo or control group, was exploratory in design, and commercial epigenetic clocks serve as proxy biomarkers rather than direct clinical outcomes.

0:36:45needs contextlowtheir own paperA Closer Look At Immune Health & Himalayan Tartary Buckwheat

In a study of healthy individuals, consuming Himalayan Tartary Buckwheat concentrate for 90 days modulated approximately 30% of genes via epigenetic remodeling.

"in our study uh with Himalayan Tartary Buckwheat in apparently healthy people we found that something on the order of 30% of their uh genes were modulated in the epigenetic remodeling by consuming 90 days of our of our Himalayan Tartary Buckwheat concentrate." (said at 0:36:45)

A 90-day open-label pilot clinical trial in 50 healthy adults (aged 18–85 years) evaluated a standardized polyphenol concentrate derived from Tartary buckwheat (Fagopyrum tataricum). The study reported significant intervention-related changes across epigenetic age clocks, immune cell subsets, and gene ontology pathways linked to longevity and immune function. However, the trial was a small, uncontrolled pilot study, meaning findings represent preliminary exploratory signals rather than definitive evidence of systemic epigenetic remodeling.

Fact-checked episodes

Publications